News
In July, Google promised to rid their platform of criminals selling pill presses. How’s it going?
As of the first week of January, we found several companies with multiple ads still running well past its self-imposed deadline. Google can do better, but will they?
[...]FDA Alert: Supplements with undeclared drug ingredients
The FDA has posted notices for two nationwide dietary supplement recalls involving products found to contain undeclared pharmaceutical ingredients.
[...]January 12, 2026: New York Department of State warned consumers after citing 87 of 223 inspected med spas
New York found widespread safety violations in med spas, and FDA inspectors cited a Texas distributor for violating the DSCSA.
[...]Prescription Drug Freight Fraud Report, November 2025
Our analysis of data in September and October 2025 revealed that large-scale freight fraud involving GLP-1s, oncology drugs, and other high-demand pharmaceuticals continues unabated.
[...]January 5, 2026: CBP Cincinnati intercepted $407,000 in illegally imported medical products, including contact lenses, injections, and oncology drugs
CBP reported seizing 450 shipments of illegally imported contact lenses and prescription medicines. Dozens of state AGs asked Meta to enforce policies against misleading weight loss products.
[...]December 15, 2025: A Massachusetts man will plead to giving botulism-causing injections, says the U.S. Attorney’s Office
The med spa owner admitted to using unapproved injectables that sickened at least 10 patients. New York authorities announced the results of a 2024 crackdown on illegal med spas. PSM published in The Journal of Illicit Trade, Financial Crime, and Compliance.
[...]PSM urges the House Energy & Commerce Committee to support the SAFE Drugs Act of 2025
PSM wrote the House Energy & Commerce Committee in support of the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act, to help protect the American drug supply from unsafely compounded medication.
[...]December 7, 2025: FDA seized more fake Ozempic pens in the U.S. supply chain
FDA announced the seizure of dozens of counterfeit Ozempic 1mg injection pens labeled with an authentic lot number, PAR1229, but displaying the expiration and lot numbers for the product in the wrong place.
[...]FDA Alert: More Counterfeit Ozempic found in U.S. Supply Chain
The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the legitimate U.S. drug supply chain. The FDA announced the seizure of multiple batches of counterfeit Ozempic 1 mg injections, labeled with lot number PAR1229, on December 5, 2025. Their contents and safety are unverified and pose serious health risks.
[...]December 1, 2025: More botulism cases underscore the need for regulated, supervised Botox use
MMWR field notes about Americans hospitalized after self-injecting imported Botox raise serious concerns about patient safety.
[...]